Most recent update: Friday, July 20, 2018 - 11:48

Bariatric News - Cookies & privacy policy

- News

Researchers at York University's Faculty of Health have found that patients who have metabolic healthy obesity - but no other metabolic risk factors - do not have an increased rate of mortality. The results of this study could impact how researchers... (more)

17/07/18 - News

Scientists at Rutgers Brain Health Institute have discovered that a small group of brain cells in the hypothalamus called 'orexin' neurons could be a promising target for medications for controlling binge eating episodes in individuals with obesity. These neurons, named for the... (more)
16/07/18 - News

The Minigastric Bypass and its Spanish variant – the One-Anastomosis Gastric Bypass, have been increasing rapidly with experience in Europe and Latin America.  Indeed, the MGB is now the most common bypass in India and in a number of Middle Eastern countries. Early postulated... (more)
13/07/18 - News

Overweight seven-year olds have a higher risk of developing type 2 diabetes as adults, but only if they are still overweight by the time they hit puberty and beyond, according to a study by researchers from Frederiksberg Hospital, Denmark. It's well known that overweight in... (more)

Gene therapy

10/07/18

Researchers from the Autonomous University of Barcelona (UAB), led by Professor Fatima Bosch, has managed to cure obesity and type 2 diabetes in...

12/07/18 - News

Type 2 diabetes is a growing concern with almost half a billion people diabetics worldwide diabetics. At least one in three adults will develop diabetes as they age, costing them both quality of life and longevity. However, for the same reasons it's becoming more common, type 2... (more)
04/07/18 - News

Nonalcoholic fatty liver disease (NAFLD) costs the US healthcare system US$32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease. The prevalence of NAFLD, which affects roughly 100 million... (more)
03/07/18 - News

Zafgen has announced positive full results from the its Phase 2 clinical trial of ZGN-1061, designed to demonstrate proof-of-concept efficacy and safety in patients with type 2 diabetes and establish a minimally effective dose. The trial met all of its primary endpoints at the 0... (more)

More news

03/07/18 - Research
T2DM medications
Zafgen has announced positive full results from the its Phase 2 clinical trial of ZGN-1061, designed to demonstrate proof-of-concept efficacy and safety in patients with type 2 diabetes and establish a minimally effective dose. The trial met all of its primary endpoints at the 0.9mg dose, and 12-... (more)
02/07/18 - Industry
Product approval
Apollo Endosurgery has received Special 510(k) clearance from the FDA for the OverStitch Sx Endoscopic Suturing System. The OverStitch Sx System is a full-thickness flexible endoscopic suturing system, received initial 510(k) clearance in November 2017. The Special 510(k) addressed an accessory to... (more)
29/06/18 - Research
Alzheimer's and obesity
When a high-fat, high-sugar diet that leads to obesity is paired with normal aging, it may contribute to the development of Alzheimer's disease, according to researchers from Brock University in Ontario, Canada. In addition, the researchers discovered that certain areas of the brain respond... (more)
27/06/18 - Industry
Intragastric Balloons
Obalon Therapeutics has commented on the advisory issued by the FDA in June concerning the potential risks, including deaths, associated with liquid-filled intragastric balloons. The advisory was specific to the Apollo Orbera and ReShape Duo intragastric balloons and does not reference or apply to... (more)
26/06/18 - Research
Metabotypes and bariatric surgery
Individuals experienced a greater improvement of insulin resistance and cardiovascular factors after bariatric surgery had lower levels of gluconeogenic precursors, metabolites of the urea metabolism associated with nitric-oxide (NO) mechanisms, and changes in the microcomponents of lipoproteins,... (more)
26/06/18 - Research
T2DM medications
In young patients with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to a study presented at the American Diabetes Association... (more)